ANI Pharmaceuticals, Inc. ANIP
Health Care · Pharmaceuticals, Biotechnology & Life Sciences · NASDAQ · United States · anipharmaceuticals.com
ANI Pharmaceuticals is a diversified biopharmaceutical company that develops, manufactures, and commercializes therapeutics through its Rare Disease business (novel products in ophthalmology, rheumatology, nephrology, neurology, and pulmonology), a U.S.-based Generics business, and an Established Brands portfolio. It also operates as a contract development and manufacturing organization (CDMO) for pharmaceutical products. The company is headquartered in Baudette, Minnesota.
Key ratios
CashFromOperationsYoYGrowth TTM 1.58
CashFromOperationsYoYGrowth 2025 1.89
CashFromOperationsYoYGrowth 2024 -0.46
FreeCashFlowOnSale 2025 0.19
FreeCashFlowOnSale 2024 0.08
FreeCashFlowOnSale 2023 0.23
NetIncomeMargin TTM 0.1
NetIncomeMargin 2025 0.09
NetIncomeMargin 2024 -0.03
NetIncomeMargin 2023 0.04
ReturnOnAssets TTM 0.05
ReturnOnAssets 2025 0.04
ReturnOnAssets 2024 0.02
ReturnOnAssets 2023 0.04
ReturnOnEquity TTM 0.18
ReturnOnEquity 2025 0.16
ReturnOnEquity 2024 -0.04
ReturnOnEquity 2023 0.05
TotalRevenueYoYGrowth TTM 0.37
TotalRevenueYoYGrowth 2025 0.44
TotalRevenueYoYGrowth 2024 0.26
TotalRevenueYoYGrowth 2023 0.54
Recent news
ANI Pharmaceuticals to Discuss Second Quarter 2026 Financial Results on August 7, 2026 at 8:00 a.m. ET
2026-07-24 · GlobeNewswire